 |
|
|
| |
Higher Rates of Neuropsychiatric Adverse Events Leading to Dolutegravir Discontinuation in Women and Older Patients
|
| |
| |
Reported by Jules Levin
HIV Glasgow Oct 23-26 2016
Michael SABRANSKI, Christoph WYEN, Tanya WELZ, Michael KOLB, Eva WOLF, Hans-Jürgen STELLBRINK, and Christian HOFFMANN
|
| |
|
|
|
|
|
